Has Shayan Irani, MD received payments from drug or device companies?

Yes. Drug and device makers reported $57,310 in general payments to Shayan Irani, MD across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shayan Irani, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shayan Irani, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shayan Irani, MD

Gastroenterology · Seattle, WANPI 1821204488

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Boston Scientific at 56.8% of the total. Reporting peaked in 2024 at $28,069 and has fallen 99.7% since, to $85 in 2025. Among gastroenterology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,310in general payments, 2019–2025

Across 92 payments — averaging $622.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$33K
W. L. Gore & Associates, Inc.$23K
Conmed Corporation$1K
Cook Medical LLC$231
Olympus America Inc.$98
Lumendi LLC$80
plus $75 from 1 others

$63,502in research payments, 2019–2025

Across 30 payments — averaging $2116.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$64K

What the payments were for

Consulting fees$21,67038%
Speaking & faculty fees$26,33046%
Travel & lodging$6,85112%
Food & beverage$2,4594%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	54	$32,562
W. L. Gore & Associates, Inc.	24	$23,004
Conmed Corporation	7	$1,261
Cook Medical LLC	4	$231
Olympus America Inc.	1	$98
Lumendi LLC	1	$80
Fujifilm Healthcare Americas Corporation	1	$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GORE VIABIL Biliary Endoprosthesis$16,795
ACQUIRE$12,980
AXIOS$11,614
Product in Development$7,475
GENERAL - THERAPIES$2,106
CONMED BILIARY$1,128
RESOLUTION CLIP$750
AUTOTOME$375
CONMED HEMOSTASIS$140
EXALT MODEL D CONTROLLER$123
Cook Medical Metal Stents$116

How this compares

$57,310 in reported general payments places this provider in the 95th percentile of 447 gastroenterology providers in Washington.

See all gastroenterology providers in Washington →

Medicare billing

Part B allowed, 2024

$266,203

Medicare patients

414

Services billed

1,981

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CreonLipase/Protease/Amylase	38	$198,536
Ursodiol	14	$2,416
Omeprazole	104	$2,190
Pantoprazole Sodium	36	$590
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	34	$546
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl	31	$488
Ondansetron Hcl	59	$195
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	13	$195
Levofloxacin	11	$34

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Seattle

Kris KowdleySeattle$1.4M
Scott LeeSeattle$220K
Alyssa ChoiSeattle$102K
Andrew RossSeattle$99K
Laurens JanssensSeattle$56K
George McDonaldSeattle$53K
Adam TempletonSeattle$49K
Sravanthi ParasaSeattle$47K
Liam HilsonSeattle$37K
Rotonya CarrSeattle$36K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →